Search Results

IWK Health becomes first site in Nova Scotia to join Breathe BioMedical’s multi-center study to advance development of its technology for early detection of breast cancer in women

Vitalité Health Network becomes the first Canadian site to join Breathe BioMedical’s multi-center study to advance development of its technology for early detection of breast cancer in women

Acceptance of TempraMed’s products by Meuhedet Health Services strengthens TempraMed’s B2B institutional commercialization strategy as the Company advances reimbursement initiatives and expands relationships with leading healthcare organizations globally Highlights Meuhedet Health Services, Israel’s third-largest Health Maintenance Organization (HMO), serving more than one million insured members, has accepted TempraMed’s flagship VIVI Cap™ and VIVI Epi™ products. TempraMed products are now accepted by two of Israel’s four national HMOs—Maccabi Healthcare Services and Meuhedet—providing institutional access to approximately four million insured lives. The Company is executing a global B2B institutional strategy focused on healthcare organizations, insurers, distributors and government healthcare systems.